Rivaroxaban
Interviews and expert commentary tagged “Rivaroxaban” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Randomized Study Confirms Rivaroxaban Oral Alternative For Cancer Thromboembolism
ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe
5 February 2018
15:00
Audio Journal of Oncology
Rivaroxaban Confirmed as Oral Alternative For Cancer Thromboembolism
ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe
5 February 2018
15:00